The promise and perils of biomarker testing in gynecologic cancers

•Biomarker testing is crucial for personalized medicine, offering benefits in treatment precision, prognosis and outcomes.•Overcoming barriers to biomarker testing utilization is essential for equitable access and optimal care for all patients.•Implementing policy change, clinical pathways, and educ...

Full description

Saved in:

Bibliographic Details
Published in:	Gynecologic oncology Vol. 201; pp. 53 - 55
Main Authors:	Fitch, Katherine C., Previs, Rebecca A., Moss, Haley A.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01.10.2025
Subjects:	Hematology, Oncology, and Palliative Medicine Obstetrics and Gynecology
ISSN:	0090-8258, 1095-6859, 1095-6859
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	•Biomarker testing is crucial for personalized medicine, offering benefits in treatment precision, prognosis and outcomes.•Overcoming barriers to biomarker testing utilization is essential for equitable access and optimal care for all patients.•Implementing policy change, clinical pathways, and educational programs can enhance the effective use of biomarker testing.
Bibliography:	SourceType-Scholarly Journals-1 content type line 23 ObjectType-Editorial-2 ObjectType-Commentary-1
ISSN:	0090-8258 1095-6859 1095-6859
DOI:	10.1016/j.ygyno.2025.07.019